SCHEMBL6947200

SCHEMBL6947200

NCCO/N=C(/CCCN1CCC(C(=O)c2ccc(F)cc2)CC1)c1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 3/20 0.57
KDM4E B2RXH2 1/20 0.57
CYP1A2 P05177 1/20 0.57
CYP3A4 P08684 1/20 0.57
CYP2D6 P10635 1/20 0.57
SLC6A4 P31645 1/20 0.50
HTR2C P28335 2/20 0.49
HTR7 P34969 2/20 0.49
HTR6 P50406 2/20 0.49
KCNH2 Q12809 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6947854 1.00 HTR2A (0.57) HTR2AKDM4ECYP1A2CYP3A4CYP2D6
Hydrochloric Acid SCHEMBL8867634 0.99 HTR2A (0.56) HTR2AKDM4ECYP1A2CYP3A4CYP2D6
Hydrochloric Acid SCHEMBL8867625 0.99 HTR2A (0.56) HTR2AKDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL6953050 0.96 HTR2A (0.53) HTR2AKDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL6948666 0.94 KCNH2 (0.54) HTR2AKDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL6948664 0.94 KCNH2 (0.54) HTR2AKDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL6947026 0.90 MEN1 (0.53) HTR2AKDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL6947024 0.90 MEN1 (0.53) HTR2AKDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL6952321 0.89 HRH2 (0.49) HTR2AKCNH2
SCHEMBL6952317 0.89 HRH2 (0.49) HTR2AKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0709378-B1 Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds AVENTIS PHARMA INC (US) 2003-03-19 EP claimed
US-5648367-A ANTIDEPRESANTS, OBSESSIVE-COMPULSIVE DISORDER HOECHST MARION ROUSSEL, INC. (US) 1997-07-15 US claimed
EP-0709378-A2 Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1996-05-01 EP claimed